PeriVision Revenue and Competitors
Estimated Revenue & Valuation
- PeriVision's total funding is $2M.
Employee Data
- PeriVision has 15 Employees.
- PeriVision grew their employee count by 0% last year.
PeriVision's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & co-founder | Reveal Email/Phone |
2 | Software QA & Product Manager | Reveal Email/Phone |
3 | Vice Chairman | Reveal Email/Phone |
4 | UI/UX Researcher | Reveal Email/Phone |
PeriVision Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 13 | 18% | N/A | N/A |
#2 | N/A | 121 | 21% | N/A | N/A |
#3 | N/A | 157 | 44% | N/A | N/A |
#4 | N/A | 15 | 0% | $2.37M | N/A |
#5 | N/A | 63 | 21% | N/A | N/A |
#6 | N/A | 127 | 44% | N/A | N/A |
#7 | N/A | 25 | 92% | $73.9M | N/A |
#8 | N/A | 1038 | 1% | N/A | N/A |
#9 | N/A | 190 | 9% | N/A | N/A |
What Is PeriVision?
Vision is the most dominant of our senses. Yet, 2.2 billion people suffer from vision impairments of which 50% could be prevented or cured. And this number is growing due to our ageing populations and modern lifestyles.\n\nAt the same time healthcare systems have limited resources. Eye care lags behind in the digital transformation and novel technology is not fully leveraged. As a result, people lose vision that do not have to.\n\nWe combine AI algorithms, virtual reality and cloud computing to build the next generation systems to test visual function. We improve workflow efficiency and provide deeper clinical insight into eye diseases. \n\nTo leverage these technologies fully, we take a disease-centric approach. The first condition we target is glaucoma. We address the large unmet need for more efficient and effective monitoring of 80M patients worldwide.
keywords:N/A$2M
Total Funding
15
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 15 | 15% | N/A |
#2 | $1.9M | 15 | -12% | N/A |
#3 | $2M | 15 | -29% | N/A |
#4 | $2.6M | 16 | -64% | N/A |
#5 | $1.3M | 16 | N/A | N/A |